Neuracle Raises ￥100M in Series B Funding Round, Led By Sequoia Capital China

(VCBeat) Mar. 19, 2021 -- Neuracle Technology (Changzhou) Co., Ltd. ("Neuracle"),  a leading company in the field of brain-computer interface in China, recently announced closing a Series B funding round of over 100 million yuan, led by Sequoia Capital China, with participation from existing investors including Co-win Ventures and Roton Capital. According to this startup, the financing will be used for product development, production line investment and sales network construction, among other things.

Neuracle is a well-known enterprise in the field of neuroscience in China. It relies on Tsinghua University's independent innovation and international leading "brain-machine interface" technology, and is committed to innovative research in the fields of neuroscience, psychology, neuroengineering, etc., providing professional and complete solutions for the diagnosis, treatment, and rehabilitation of program about clinical neurological diseases. Their products cover a wide range of fields including clinical medicine, neuroscience, psychology, management marketing, etc., and take the lead in undertaking the National Twelfth Five-Year Science and Technology Support Program. 

In close cooperation with brain science professionals and clinical neurotherapists, Neuracle is developing a new minimally invasive brain-computer interface system, in which a coin-sized internal machine is buried in the skull and communicates wirelessly with the external device through the skin. It can ensure the signal quality without damaging the dura mural and nerve cells. "We found a balance between signal strength and implant damage," said Professor Hong Bo, an expert on brain-computer interfaces at Tsinghua University, "The stable environment inside the skull ensures long-term and reliable signal quality, which can not only collect brain signals accurately but also realize closed-loop feedback. This is a unique brain-computer interface solution that can achieve long-term stable bidirectional brain-computer interface."

Sequoia Capital China is a VC firm focused on seed-stage, mid-stage, late-stage, and growth investments in the fintech sector.

Formed in September 2005, Sequoia Capital China has an impressive and diverse portfolio comprising about 300 dynamic companies that deliver high returns on investment using differentiated technologies and innovative business models, including Alibaba, VIPshop.com, Sina.com, Didi, JD.com, Ourpalm, Qihoo 360, Jumei, Momo, and so on.

Founded in 2009, Co-win Ventures is an angel and early-stage investor in TMT and Healthcare. They keep nurturing growth-stage companies graduated from their angel investment portfolio and our funds encompass the whole financial product chain, including seed funds, VC funds and PE funds. Co-win Ventures' business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing, Shenzhen and Hong Kong.